Denali Therapeutics Inc. (DNLI) Goodwill and other intangible assets — Quarterly & Annual

Screener

Goodwill and other intangible assets at other companies

TrupanionTRUP

$3.7M—

Senseonics Holdings, Inc.SENS

$700K—

Denali Therapeutics Inc.DNLI

$36M—

Amneal Pharmaceuticals, Inc.AMRX

$10.75M+103%

Louisiana-Pacific CorporationLPX

$22M-15.4%

Louisiana-Pacific CorporationLPX

$22M-15.4%

Other financials

Income statement

Revenue$3.6M—

Gross profit$3.5M—

Operating income-$130.5M+3.3%

Net income-$127.6M-2.8%

EPS (diluted)-$0.68+5.6%

Balance sheet

Cash & equivalents$204.6M+41.8%

Total debt$37.7M-21.4%

Total equity$835.2M-18.7%

Total assets$1.2B-0.7%

Cash flow

Operating cash flow-$97.0M-28.8%

CapEx$805.0K-81.2%

Free cash flow-$97.8M-22.9%

Valuation

Market cap$3.88B+85.9%

Enterprise value$3.71B+86.5%

P/S1,075.4×+1,071×

Profitability

Operating margin-37,938%-37,986pp

Net margin-33,121.9%-33,159pp

FCF margin-31,736.3%-31,830pp

Returns & leverage

Return on equity-54.9%+34.3pp

Debt / equity0×0.0×

Current ratio8.4×-1.9×

Where this comes from

Reported directly by Denali Therapeutics Inc. in its filing.

Tagged under the XBRL concept us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1.

The source filing: Denali Therapeutics Inc.’s 10-Q, filed May 7, 2026. Open the filing →

Filed: May 7, 2026, 4:12 PM EDT
Fiscal quarter: Q1 FY2026
Calendar quarter: Q1 2026
Accession: 0001714899-26-000064

FAQ

What is Denali Therapeutics Inc.'s goodwill and other intangible assets?: Denali Therapeutics Inc. (DNLI) reported goodwill and other intangible assets of $36M in Q1 2026.
What does goodwill and other intangible assets mean?: Goodwill and other intangible assets as reported by Denali Therapeutics Inc. Common Stock.

Ask your AI about Denali Therapeutics Inc.'s goodwill and other intangible assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk